Excellence in life sciences executive search

Recent News

The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals

June 23, 2021
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate… Continue Reading →

The Chase Group Secures Teng Jin Ong for Genmab

May 28, 2021
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new clinical development medical executive as they work to pioneer the… Continue Reading →

Ventria Bioscience Cuts to The Chase!

May 6, 2021
Ventria Bioscience is embarking on a path of accelerated growth as they work to double their capacity for multiple products this year. As part of… Continue Reading →

Genmab Continues Partnership With The Chase Group As Their Drug Safety Leadership Team Grows

April 20, 2021
Over the past three years, Genmab has retained The Chase Group to execute four Director, Drug Safety and Pharmacovigilance (PV) physician searches that all concluded… Continue Reading →

Ferrer Partners With The Chase Group to Identify US Business Development Leader

March 18, 2021
The Chase Group’s successful partnership with Alexza Pharmaceuticals has extended to include their parent company, Ferrer. A privately held company based in Barcelona, Spain, Ferrer… Continue Reading →

The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals

March 10, 2021
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… Continue Reading →

The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics

March 3, 2021
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,… Continue Reading →

Alexza Pharmaceuticals Continues Partnership With The Chase Group to Seek Clinical Operations Leader

January 27, 2021
Alexza Pharmaceuticals, backed by their parent company, Ferrer, is working to develop products for the acute treatment of underserved medical needs in neuroscience. The company… Continue Reading →

The Chase Group Retained by Checkmate Pharmaceuticals to Identify Head of Regulatory Affairs

January 15, 2021
Checkmate Pharmaceuticals has once again partnered with The Chase Group to continue building its team of life sciences entrepreneurs who are devoted to discovering and… Continue Reading →

The Chase Group Successfully Completes Search for Vice President, Research & Development at Alexza Pharmaceuticals

Alexza Pharmaceuticals stands at the crossroads of innovation and advanced technology with a platform that has the potential to address unmet medical needs in neuroscience…. Continue Reading →
Copyright © 1993-2024 The Chase Group. All Rights Reserved.